Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Indinavir can cause hair loss and other skin problems.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

A man with HIV developed skin and hair issues after starting HIV treatment, which improved with topical treatment.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Switching from escitalopram to duloxetine improved hair loss.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

Upadacitinib effectively treats psoriasis and lichen planus together.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Eclipta alba leaf alkaloids may help treat HIV by inhibiting the virus's activity.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

A new delivery system makes Curcumin more effective and safer against viruses.

Most patients on this hepatitis C treatment experienced skin issues, especially hair loss.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Divalproex sodium significantly improved headaches in two-thirds of patients.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.